Serum C-19 Steroid Sulphates in Females with Clinical Hyperandrogenism
 January 1989   
in “
 Journal of Steroid Biochemistry 
”
 
    hyperandrogenism  premature adrenarche  late onset 21 hydroxylase deficiency  polycystic ovarian disease  idiopathic hirsutism  androgenic alopecia  sex hormone binding globulin  dehydroepiandrosterone sulphate  testosterone  5-androstene-3ß,17ß-diol sulphate  5α-androstane-3α,17ß-diol sulphate  androgens  peripheral androgen metabolism  PA  LOCAH  PCOD  IH  AA  SHBG  DHEA-S  T  5-ADIOL-S  3α-DIOL-S   
    
   TLDR  Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.   
  In a study from 1989, researchers investigated serum levels of androgens and steroid sulphates in females with various forms of hyperandrogenism, including premature adrenarche (PA, n = 9–16), late onset 21 hydroxylase deficiency (LOCAH, n = 14), polycystic ovarian disease (PCOD, n = 28), idiopathic hirsutism (IH, n = 74), and androgenic alopecia (AA, n = 35–45), compared to normal prepubertal girls (n = 9-14) and normal adult women (n = 50–73). The study found elevated levels of certain androgens and a lower level of sex hormone binding globulin (SHBG) in all patient groups except for dehydroepiandrosterone sulphate (DHEA-S) and testosterone (T) in the alopecia group. The study concluded that 5-androstene-3ß,17ß-diol sulphate (5-ADIOL-S) might act as a pro-hormone in the synthesis of more potent androgens in the skin, and that 5α-androstane-3α,17ß-diol sulphate (3α-DIOL-S) could be a marker of peripheral androgen metabolism. These factors seem to play a role in hirsutism and premature pubic hair development in girls, and in androgenic alopecia, 5-ADIOL-S and free testosterone may be particularly significant.
    
   
   
   
   
   
  